Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CryoCor

2000 FOUNDED
M&A STATUS
31-40 EMPLOYEES
M&A LATEST DEAL TYPE
$17.6M LATEST DEAL AMOUNT
Description

Manufacturer of a medical device to treat cardiac arrhythmias. The company offers a proprietary technical device which can be used in surgeries to treat cardiac arrhythmias by creating electrically isolating lesions using cold energy. The treatment enables patients with atrial fibrillation, atrial flutter and other cardiac arythmias to lead normal lives.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Acquirer
Boston Scientific
Primary Office
  • 9717 Pacific Heights Boulevard
  • San Diego, CA 92121
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CryoCor’s full profile, request a free trial.

CryoCor Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 28-May-2008 $17.6M 00000 000.00 Completed Generating Revenue
6. Convertible Debt 22-Jun-2007 0000 00000 Completed Generating Revenue
5. IPO 19-Jul-2005 000.00 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series D) 01-May-2004 000.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 18-Jan-2002 0000 000.00 000.00 Completed Product Development
2. Early Stage VC (Series B) 31-Aug-2000 $7M $11.9M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 31-Aug-2000 $4.86M $4.86M 00.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

CryoCor Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series D1 00,000,000 00.000000 00.0 00.0 00 00.0
Series D 000,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series C 0,000,000 00.000000 00 00.0 00.0 00 00.00 00.000
Series B 1,620,368 $0.001000 8% $4.32 $4.32 1x $0.5 7.29%
Series A 1,881,933 $0.001000 8% $2.58 $2.58 1x $0.41 6.11%
To view this company’s complete Cap Table, request access »

CryoCor Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ATEL Capital Group Lender/Debt Provider Minority 000 0000 000000 0
Beecken Petty O'Keefe & Company PE/Buyout Minority 000 0000 000000 0
Chicago Growth Partners PE/Buyout Minority 000 0000 000000 0
Community Investment Venture Capital Minority 000 0000 000000 0
Cross Creek Advisors Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

CryoCor Executive Team (4)

Name Title Board
Seat
Contact
Info
Gregory Tibbitts Chief Financial Officer & Vice President, Finance

3 Former Executives

You’re viewing 1 of 4 executives. Get the full list »